These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2472227)

  • 1. Cellular metabolism of 5,6-dihydro-5-azacytidine and its incorporation into DNA and RNA of human lymphoid cells CEM/O and CEM/dCk(-).
    Avramis VI; Powell WC; Mecum RA
    Cancer Chemother Pharmacol; 1989; 24(3):155-60. PubMed ID: 2472227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular metabolism of 1-beta-D-arabinofuranosyl-5-azacytosine and incorporation into DNA and RNA of human lymphoid CEM/0 and CEM/dCk(-) cells.
    Avramis VI; Powell WC; Mecum RA
    Cancer Chemother Pharmacol; 1989; 25(1):19-24. PubMed ID: 2480187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 5-azacytidine and congeners on DNA methylation and expression of deoxycytidine kinase in the human lymphoid cell lines CCRF/CEM/0 and CCRF/CEM/dCk-1.
    Antonsson BE; Avramis VI; Nyce J; Holcenberg JS
    Cancer Res; 1987 Jul; 47(14):3672-8. PubMed ID: 2439195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical pharmacology of 5,6-dihydro-5-azacytidine (DHAC) and DNA hypomethylation in tumor (L1210)-bearing mice.
    Powell WC; Avramis VI
    Cancer Chemother Pharmacol; 1988; 21(2):117-21. PubMed ID: 2450689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical pharmacology and DNA methylation studies of arabinosyl 5-azacytidine and 5,6-dihydro-5-azacytidine in two human leukemia cell lines PER-145 and PER-163.
    Kees UR; Avramis VI
    Anticancer Drugs; 1995 Apr; 6(2):303-10. PubMed ID: 7540895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of deoxycytidine kinase by 5-azacytidine in an HL-60 cell line resistant to arabinosylcytosine.
    Kong XB; Tong WP; Chou TC
    Mol Pharmacol; 1991 Feb; 39(2):250-7. PubMed ID: 1705001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic and DNA methylation studies of high-dose 1-beta-D-arabinofuranosyl cytosine before and after in vivo 5-azacytidine treatment in pediatric patients with refractory acute lymphocytic leukemia.
    Avramis VI; Mecum RA; Nyce J; Steele DA; Holcenberg JS
    Cancer Chemother Pharmacol; 1989; 24(4):203-10. PubMed ID: 2473850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular pharmacodynamic studies of the synergistic combination of 6-mercaptopurine and cytosine arabinoside in human leukemia cell lines.
    Ramilo-Torno LV; Avramis VI
    Cancer Chemother Pharmacol; 1995; 35(3):191-9. PubMed ID: 7805176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of DNA methylation of the 5' region of the deoxycytidine kinase gene in CCRF-CEM-sensitive and cladribine (CdA)- and 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine (CAFdA)-resistant cells.
    Leegwater PA; De Abreu RA; Albertioni F
    Cancer Lett; 1998 Aug; 130(1-2):169-73. PubMed ID: 9751270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-aza-2'-deoxycytidine therapy in patients with acute leukemia inhibits DNA methylation.
    Momparler RL; Bouchard J; Onetto N; Rivard GE
    Leuk Res; 1984; 8(2):181-5. PubMed ID: 6201685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleosides and nucleotides. 180. Synthesis and antitumor activity of nucleosides that have a hydroxylamino group instead of a hydroxyl group at the 2'- or 3'-position of the sugar moiety.
    Ogawa A; Tanaka M; Sasaki T; Matsuda A
    J Med Chem; 1998 Dec; 41(25):5094-107. PubMed ID: 9836625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difluorodeoxyguanosine: cytotoxicity, metabolism, and actions on DNA synthesis in human leukemia cells.
    Gandhi V; Mineishi S; Huang P; Yang Y; Chubb S; Chapman AJ; Nowak BJ; Hertel LW; Plunkett W
    Semin Oncol; 1995 Aug; 22(4 Suppl 11):61-7. PubMed ID: 7481847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative effects and DNA hypomethylation by 5-aza-2'-deoxycytidine in human neuroblastoma cell lines.
    Carpinelli P; Granata F; Augusti-Tocco G; Rossi M; Bartolucci S
    Anticancer Drugs; 1993 Dec; 4(6):629-35. PubMed ID: 7507741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2',2'-Difluoro-deoxycytidine (gemcitabine) incorporation into RNA and DNA of tumour cell lines.
    Ruiz van Haperen VW; Veerman G; Vermorken JB; Peters GJ
    Biochem Pharmacol; 1993 Aug; 46(4):762-6. PubMed ID: 8363650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of human equilibrative nucleoside transporter 1 on the cellular transport of the DNA methyltransferase inhibitors 5-azacytidine and CP-4200 in human leukemia cells.
    Hummel-Eisenbeiss J; Hascher A; Hals PA; Sandvold ML; Müller-Tidow C; Lyko F; Rius M
    Mol Pharmacol; 2013 Sep; 84(3):438-50. PubMed ID: 23814180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5,6 Dihydro-5'-azacytidine (DHAC) restores androgen responsiveness in androgen-insensitive prostate cancer cells.
    Izbicka E; MacDonald JR; Davidson K; Lawrence RA; Gomez L; Von Hoff DD
    Anticancer Res; 1999; 19(2A):1285-91. PubMed ID: 10368689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of primer RNA formation in CCRF-CEM leukemia cells by fludarabine triphosphate.
    Catapano CV; Chandler KB; Fernandes DJ
    Cancer Res; 1991 Apr; 51(7):1829-35. PubMed ID: 1706219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.
    Taub JW; Huang X; Ge Y; Dutcher JA; Stout ML; Mohammad RM; Ravindranath Y; Matherly LH
    Cancer Res; 2000 Nov; 60(22):6421-6. PubMed ID: 11103808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of cancer cells with methioninase produces DNA hypomethylation and increases DNA synthesis.
    Machover D; Zittoun J; Saffroy R; Broët P; Giraudier S; Magnaldo T; Goldschmidt E; Debuire B; Orrico M; Tan Y; Mishal Z; Chevallier O; Tonetti C; Jouault H; Ulusakarya A; Tanguy ML; Metzger G; Hoffman RM
    Cancer Res; 2002 Aug; 62(16):4685-9. PubMed ID: 12183426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to the methylation inhibitor dihydro-5-azacytidine in mesothelioma is not associated with methylation of p16INK4a: results of cancer and leukemia group B 159904.
    Kratzke RA; Wang X; Wong L; Kratzke MG; Green MR; Vokes EE; Vogelzang NJ; Kindler HL; Kern JA;
    J Thorac Oncol; 2008 Apr; 3(4):417-21. PubMed ID: 18379362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.